GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Synergy CHC Corp (OTCPK:SNYR) » Definitions » Change In Payables And Accrued Expense

Synergy CHC (Synergy CHC) Change In Payables And Accrued Expense : $-2.65 Mil (TTM As of Mar. 2020)


View and export this data going back to 2013. Start your Free Trial

What is Synergy CHC Change In Payables And Accrued Expense?

Synergy CHC's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2020 was $-0.66 Mil. It means Synergy CHC's Accounts Payable & Accrued Expense declined by $0.66 Mil from Dec. 2019 to Mar. 2020 .

Synergy CHC's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2019 was $-3.73 Mil. It means Synergy CHC's Accounts Payable & Accrued Expense declined by $3.73 Mil from Dec. 2018 to Dec. 2019 .


Synergy CHC Change In Payables And Accrued Expense Historical Data

The historical data trend for Synergy CHC's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy CHC Change In Payables And Accrued Expense Chart

Synergy CHC Annual Data
Trend Jul12 Jul13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Change In Payables And Accrued Expense
Get a 7-Day Free Trial 0.48 -0.44 -1.29 3.28 -3.73

Synergy CHC Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.74 -1.61 -0.68 0.30 -0.66

Synergy CHC Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synergy CHC Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Synergy CHC's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy CHC (Synergy CHC) Business Description

Industry
Traded in Other Exchanges
N/A
Address
865 Spring Street, Westbrook, ME, USA, 04092
Synergy CHC Corp is a consumer health care company. It is in the business of marketing and distributing consumer branded products through various distribution channels primarily in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Synergy generates the majority of its revenue from the sale of Flat Tummy Tea, which is exclusively sold online at www.flattummyco.com. Flat Tummy Tea is a uniquely formulated two-step herbal detox tea that works to naturally help speed metabolism, boost energy and reduce bloating.
Executives
Jack Ross director, 10 percent owner, officer: President, CEO and CFO 3435 OCEAN PARK BLVD. #107 SANTA MONICA CA 90405
Patrick S. Mccullough officer: President C/O SYNERGY CHC CORP. 865 SPRING STREET WESTBROOK ME 04092
Jeffrey Kadanoff officer: Chief Financial Officer C/O SYNERGY CHC CORP. 865 SPRING STREET WESTBOOK ME 04902
Gale K. Bensussen director C/O SYNERGY CHC CORP. 865 SPRING STREET WESTBROOK ME 04092
Knight Therapeutics (barbados) Inc. 10 percent owner CHANCERY HOUSE HIGH STREET BRIDGETOWN C8 BB11128
Stephen J Fryer director
James Paul Sorelle director 3435 OCEAN PARK BLVD #107 SANTA MONICA CA 90405
Gowan Private Equity Inc. 10 percent owner 275 CANTERBURY LANE FALL RIVER A5 B2T1A4

Synergy CHC (Synergy CHC) Headlines

From GuruFocus

Flat Tummy App Has Phenomenal Launch Babenation Can't Get Enough

By Marketwired Marketwired 11-19-2019

Synergy CHC Corp. Announces Third Quarter 2018 Results

By Marketwired Marketwired 11-13-2018

Synergy CHC Corp. Announces Second Quarter 2019 Results

By Marketwired Marketwired 08-14-2019

Synergy CHC Corp. Announces Insider Buying

By Marketwired Marketwired 12-10-2018

Synergy CHC Corp. Announces First Quarter 2019 Results

By Marketwired Marketwired 05-03-2019

Synergy CHC Corp. Announces Fiscal 2018 Year End Results

By Marketwired Marketwired 03-30-2019

Synergy CHC Corp. Announces Fiscal 2017 Year End Results

By Marketwired Marketwired 04-02-2018

Synergy CHC Corp. Announces Third Quarter 2019 Results

By Marketwired Marketwired 11-14-2019